Press release
Neuromyelitis Optica Market Will Accelerate Rapidly with Excellent Future CAGR Highlighting Top Prominent Players: Alexion Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, Viela Bio.
Neuromyelitis Optica Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/neuromyelitis-optica-market
The Neuromyelitis Optica (Devic's Syndrome) Market is estimated to reach at a CAGR of 4.8% during the forecast period 2024-2031.
The Neuromyelitis Optica (NMO) or Devic's Syndrome market focuses on the development and distribution of treatments for this rare autoimmune disorder that affects the central nervous system, particularly the optic nerves and spinal cord. Key therapies include immunosuppressive drugs, monoclonal antibodies, and plasma exchange to manage relapses and prevent disease progression. Market growth is driven by increased awareness, advancements in diagnostic tools, ongoing research into targeted therapies, and the rising prevalence of autoimmune diseases. Additionally, emerging biologics and personalized treatment options are contributing to the expansion of the NMO therapeutic landscape.
Key Players
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Neuromyelitis Optica market research report are:
Alexion Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, Viela Bio, Genentech, Inc., AstraZeneca, Shanghai Pharmaceutical Group Co., Ltd., China Resources Pharmaceutical GroupCo., Ltd. and Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. SAGENT PHARMACEUTICALS, INC. and ZYDUS PHARMACEUTICALS, INC.
Key Development
On June 27, 2019, Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced that the U.S. FDA had approved SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who test positive for anti-aquaporin-4 (AQP4) antibodies. Around 73% of NMOSD patients are positive for these auto-antibodies. The FDA's approval of SOLIRIS came after an expedited six-month priority review.
Regions Covered:
The global Neuromyelitis Optica Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=neuromyelitis-optica-market
Market Segments
By Product Type: Eculizumab, Methylprednisolone, Azathioprine, Mycophenolate Mofetil, Rituximab.
By Application: Hospitals, Clinics, Homecare and Telemedicine.
The Neuromyelitis Optica industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
Meet critical unmet needs in complex conditions with advanced, precise Neuromyelitis Optica industry solutions for better diagnostics and outcomes.
Stay ahead with real-time pipeline analysis, revealing the latest Neuromyelitis Optica innovations and market trends.
Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
Protect your innovation with expert patent analysis, ensuring strategic positioning in the Neuromyelitis Optica market.
Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Neuromyelitis Optica.
Maximize market presence with brand share analysis, strengthening your position in the Neuromyelitis Optica landscape.
Accurately predict market demand for Neuromyelitis Optica with precise drug sales forecasting insights.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/neuromyelitis-optica-market
FAQs
Which region is expected to have the highest market Share during the forecast period?
North America is expected to have the highest market share during the forecast period.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromyelitis Optica Market Will Accelerate Rapidly with Excellent Future CAGR Highlighting Top Prominent Players: Alexion Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, Viela Bio. here
News-ID: 3704192 • Views: …
More Releases from DataM Intelligence 4Market Research
Green Steel Market is expected to reach US$ 140,435.7 million by 2031 | Major Co …
Market Size and Growth:
The Global Green Steel Market size reached US$ 201.3 million in 2022 and is expected to reach US$ 140,435.7 million by 2031, growing with a CAGR of 126.7% during the forecast period 2024-2031. According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/green-steel-market?sz
The Green Steel Market refers to the global industry involved in the production, distribution, and adoption of environmentally sustainable steel. It focuses on reducing…
Bauxite Market is expected to reach US$ 19.7 billion by 2030 | Top Companies - R …
Market Size and Growth:
The Global Bauxite Market Size reached US$ 14.8 billion in 2022 and is expected to reach US$ 19.7 billion by 2030, growing with a CAGR of 3.7% during the forecast period 2024-2031. According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/bauxite-market?sz
The Bauxite Market refers to the global trade and production of bauxite, the primary ore for aluminum. It encompasses mining, processing, and distribution activities,…
Construction Aluminum Market is expected to reach US$1,20,653.41 million by 2032 …
Market Size and Growth:
The Global Construction Aluminum Market Size reached US$75,345.01 million in 2024 and is expected to reach US$1,20,653.41 million by 2032, growing at a CAGR of 6.17% during the forecast period 2025-2032. According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/construction-aluminum-market?sz
The Construction Aluminum Market refers to the global industry involved in the production, distribution, and use of aluminum materials for construction purposes. It includes aluminum products…
Integrated Workplace Management Market 2025-2032 | Latest Developments & Growth …
Market Overview:
The Global Integrated Workplace Management Market is estimated to reach at a CAGR of 12.5% within the forecast period (2024-2031). According to DataM Intelligence Report.
Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/integrated-workplace-management-market?sz
The Integrated Workplace Management System (IWMS) Market encompasses software solutions that help organizations efficiently manage real estate, facilities, and workplace resources. It integrates space planning, asset management, maintenance, energy optimization, and workplace analytics, enhancing operational efficiency, cost savings, and…
More Releases for Neuromyelitis
Neuromyelitis Optica Market Detailed Industry Report Analysis 2025-2034
Introduction
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder of the central nervous system characterized by severe inflammation of the optic nerves and spinal cord. Patients often experience vision loss, paralysis, sensory impairment, and bladder dysfunction. Once considered a variant of multiple sclerosis (MS), NMO is now recognized as a distinct condition, thanks to advancements in diagnostics such as aquaporin-4 (AQP4) antibody testing.
Though rare, NMO can…
Neuromyelitis Optica Spectrum Disorder Market
According to a new market research report published by Global Market Estimates, the Global Neuromyelitis Optica Spectrum Disorder Market is projected to grow at a CAGR of 6.2% from 2023 to 2028.
F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi (France), Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Zydus Cadila, Boehringer Ingelheim International GmbH., Apotex Inc., and AstraZeneca among others, are some of the key players in the global…
Neuromyelitis Optica Drug Market Therapeutic Survey Reviews, Analysis 2025
The report titled “Neuromyelitis Optica Drug Market” has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners, and industry experts.
The Neuromyelitis Optica Drug was valued…
Top News: Neuromyelitis Optica Spectrum Disorder Market Advancements 2019 - 2027
Neuromyelitis Optica Spectrum Disorder Market: Introduction
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of central nervous system which was previously known as Devic disease or neuromyelitis optica (NMO). It is a rare debilitating and lifelong disease characterized by inflammation in spinal cord and optic nerve.
View Report : https://www.transparencymarketresearch.com/neuromyelitis-optica-spectrum-disorder-market.html
People with neuromyelitis optica spectrum disorder experience symptoms such as paralysis, muscle weakness, and blindness. Neuromyelitis optica spectrum disorder is most common…
Neuromyelitis Optica Therapy Market 2020 Analysis and Research Report 2025
The Neuromyelitis Optica Therapy Market report is a collection of useful information, quantitative and qualitative estimation by industry experts, the contribution from industry connoisseurs and industry accomplices across the value chain. Furthermore, the report also provides the qualitative results of diverse market factors on its geographies and segments.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and…
Global Neuromyelitis Optica Drug Market Research Report 2016
Qyresearchreports include new market research report”Global Neuromyelitis Optica Drug Market Research Report 2016″ to its huge collection of research reports.
A new research report on the global Neuromyelitis Optica Drug market offers a 360-degree overview of it. The report discusses the market in significant details and elucidates all aspects of the global Neuromyelitis Optica Drug market likely to impact its growth trajectory in the upcoming years. Major market stimulants and deterrents…
